Nomura Holdings’s Abiomed Inc ABMD Stock Holding History

Nomura Holdings’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-8,000	Closed	-$2.59M	–	1462
2018 Q4	$2.59M	Buy	+8,000	New	+$2.78M	0.01%	644

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nomura Holdings's ABMD Position: Q2 2022 in Review

Nomura Holdings sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 1,207 shares — an estimated $409K sold.

Nomura Holdings first reported a position in ABMD in Q2 2013 and held it in 20 quarters. The position peaked at $30.1M in Q2 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

Nomura Holdings reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
Nomura Holdings sold 1,207 Abiomed Inc shares in Q2 2022, an estimated $409K.
Nomura Holdings first reported a position in Abiomed Inc in Q2 2013 and held it in 20 quarters.
Nomura Holdings's Abiomed Inc position peaked at $30.1M in Q2 2018.
496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Nomura Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.